In March 2019, the FTC and the FDA issued joint warning letters to CBD companies making similar health claims. The FTC did not identify the companies that received these warning letters by name given the ongoing enforcement efforts. If you are a CBD company, or are thinking of investing in a CBD company, make sure any health-related claims—including sponsored testimonials or statements made by a brand’s influencers—are legitimately supported by reliable scientific evidence. We are continuing to monitor the federal government’s efforts to prohibit allegedly deceptive health claims on our blog. These new warning letters are part of an ongoing effort by the FTC and the Food and Drug Administration (FDA) to ensure that claims regarding the health benefits of CBD are supported by competent and reliable scientific evidence.
Authors Ryan Holz, Wasim Bleibel
| Sep 12, 2019 |
According to its press release yesterday, the Federal Trade Commission (FTC) recently issued warning letters to three companies in the cannabidiol (CBD) industry touting unsubstantiated claims that their products can prevent, treat, or cure serious diseases and health conditions. These new warning letters are part of an ongoing effort by the FTC and the Food and...
Read the full article @ Cannabis Law Report